Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

HPV persistence and its oncogenic role in prostate tumors.

Tachezy R, Hrbacek J, Heracek J, Salakova M, Smahelova J, Ludvikova V, Svec A, Urban M, Hamsikova E.

J Med Virol. 2012 Oct;84(10):1636-45. doi: 10.1002/jmv.23367.

PMID:
22930513
2.

A multifaceted study of human papillomavirus and prostate carcinoma.

Strickler HD, Burk R, Shah K, Viscidi R, Jackson A, Pizza G, Bertoni F, Schiller JT, Manns A, Metcalf R, Qu W, Goedert JJ.

Cancer. 1998 Mar 15;82(6):1118-25.

PMID:
9506358
3.

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernández L, Idris A, Sánchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer CJ, Viscidi R, Muñoz N, Franceschi S; IARC Multicenter Oral Cancer Study Group.

J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83.

PMID:
14652239
4.

Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies.

Carozzi F, Lombardi FC, Zendron P, Confortini M, Sani C, Bisanzi S, Pontenani G, Ciatto S.

Int J Biol Markers. 2004 Oct-Dec;19(4):257-61.

PMID:
15646830
5.

Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males.

Wideroff L, Schottenfeld D, Carey TE, Beals T, Fu G, Sakr W, Sarkar F, Schork A, Grossman HB, Shaw MW.

Prostate. 1996 Feb;28(2):117-23.

PMID:
8604392
6.

The role of human papillomavirus infection in prostate carcinoma.

Aghakhani A, Hamkar R, Parvin M, Ghavami N, Nadri M, Pakfetrat A, Banifazl M, Eslamifar A, Izadi N, Jam S, Ramezani A.

Scand J Infect Dis. 2011 Jan;43(1):64-9. doi: 10.3109/00365548.2010.502904. Epub 2010 Jul 22.

PMID:
20662618
7.

Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles.

Tachezy R, Hamsíková E, Hájek T, Mikysková I, Smahel M, Van Ranst M, Kanka J, Havránková A, Rob L, Guttner V, Slavík V, Anton M, Kratochvíl B, Kotrsová L, Vonka V.

J Med Virol. 1999 Aug;58(4):378-86.

PMID:
10421405
8.

Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil.

Silvestre RV, Leal MF, Demachki S, Nahum MC, Bernardes JG, Rabenhorst SH, Smith Mde A, Mello WA, Guimarães AC, Burbano RR.

Mem Inst Oswaldo Cruz. 2009 Jul;104(4):665-7.

9.

Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients.

Chen AC, Waterboer T, Keleher A, Morrison B, Jindal S, McMillan D, Nicol D, Gardiner RA, McMillan NA, Antonsson A.

Pathol Oncol Res. 2011 Sep;17(3):613-7. doi: 10.1007/s12253-010-9357-4. Epub 2011 Jan 16.

PMID:
21240663
10.
11.

High prevalence of human papillomavirus in prostate tissues.

McNicol PJ, Dodd JG.

J Urol. 1991 Apr;145(4):850-3.

PMID:
1848641
12.

Molecular and serological evidence of the epidemiological association of HPV 13 with focal epithelial hyperplasia: a case-control study.

Cuberos V, Perez J, Lopez CJ, Castro F, Gonzalez LV, Correa LA, Sanclemente G, Gaviria A, Müller M, Sanchez GI.

J Clin Virol. 2006 Sep;37(1):21-6. Epub 2006 Jun 21.

PMID:
16793332
13.
14.

Demographic and risk factors in patients with head and neck tumors.

Tachezy R, Klozar J, Rubenstein L, Smith E, Saláková M, Smahelová J, Ludvíková V, Rotnáglová E, Kodet R, Hamsíková E.

J Med Virol. 2009 May;81(5):878-87. doi: 10.1002/jmv.21470.

PMID:
19319944
15.

Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.

Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, de Villiers EM, Forslund O, Pawlita M, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):189-95. doi: 10.1158/1055-9965.EPI-07-0405.

16.

Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR).

Sarkar FH, Sakr WA, Li YW, Sreepathi P, Crissman JD.

Prostate. 1993;22(2):171-80.

PMID:
8384363
19.

Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.

Kreimer AR, Alberg AJ, Viscidi R, Gillison ML.

Sex Transm Dis. 2004 Apr;31(4):247-56.

PMID:
15028941
20.

Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study.

Adami HO, Kuper H, Andersson SO, Bergström R, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):872-5.

Supplemental Content

Support Center